Shareholding results provide a detailed breakdown of ownership in a company, including the percentage of shares held by different types of investors. This data is essential for understanding the concentration of ownership and the influence of major stakeholders. Evaluating shareholding results can help investors make informed decisions about the company’s market position and future prospects.
Sun Pharma Advanced Research C has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name |
Previous Quarter Quantity |
Current Quarter Quantity |
Previous Quarter Shares(in %) |
Current Quarter Shares(in %) |
Quarter to Quarter Difference |
Promoters |
21.31 Cr |
21.31 Cr |
65.67 |
65.67 |
0 |
Public |
11.14 Cr |
11.14 Cr |
31.95 |
31.46 |
-0.49 % |
DII
|
7.40 Lakh |
20.62 Lakh |
0.23 |
0.64 |
+0.41 % |
FII
|
69.70 Lakh |
72.33 Lakh |
2.15 |
2.23 |
+0.08 % |
Government
|
668 |
668 |
0 |
0 |
0 |
Promoters shareholding remained stable, at 65.67% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. The percentage of shares held by the public decreased from 31.95% in September 2024- to 31.46% in December 2024-.This reduction indicates that the public’s stake in the company diminished during this period.DIIs (Domestic Institutional Investors) shareholding increased from 0.23% in September 2024-2025 to 0.64% in December 2024 , indicating that domestic institutions increased their stake in the company by 0.41% . FIIs (Foreign Institutional Investors): There was a significant increase from 2.15% in September 2024-2025 to 2.23% in December 2024-2025. This suggests that foreign institutions grew their investments 0.08 in the company during the quarter. During quater from September 2024- to December 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Below is a detailed table showcasing the public shareholding percentage.
Shareholder Name |
Previous Quarter Quantity |
Current Quarter Quantity |
Previous Quarter Shares (in %) |
Current Quarter Shares (in %) |
Quarter-to-Quarter Difference (%) |
Resident Individuals holding nominal share capital up to Rs. 2 lakhs |
4.31 Cr |
4.40 Cr |
13.27 |
13.56 |
+ 0.29 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs |
1.93 Cr |
1.73 Cr |
5.93 |
5.33 |
-0.6 % |
Non Resident Indians (NRIs) |
21.95 Lakh |
23.70 Lakh |
0.68 |
0.73 |
+ 0.05 % |
Bodies Corporate |
2.28 Cr |
2.30 Cr |
7.02 |
7.09 |
+ 0.07 % |
Any Other (specify) |
42.82 Lakh |
33.28 Lakh |
1.32 |
1.03 |
-0.29 % |
HUF |
20.97 Lakh |
22.19 Lakh |
0.65 |
0.68 |
+ 0.03 % |
Body Corp- Liability Partnership |
21.59 Lakh |
10.86 Lakh |
0.67 |
0.33 |
-0.34 % |
Paresh Mohanlal Parekh |
36.47 Lakh |
0 |
1.12 |
0 |
-1.12% |
Vijay Mohanlal Parekh |
36.61 Lakh |
0 |
1.13 |
0 |
-1.13% |
Jhunjhunwala Rekha Rakesh |
62.92 Lakh |
0 |
1.94 |
0 |
-1.94% |
Enam Securities |
33.71 Lakh |
0 |
1.04 |
0 |
-1.04% |
Lakshdeep Investments & Finance . |
60.34 Lakh |
0 |
1.86 |
0 |
-1.86% |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.29 %.Observations show a significant difference of -0.6 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.05 %.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.07 %.Observations show a significant difference of -0.29 % in Any Other (specify)’s financial performance between quarters.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.03 %.Observations show a significant difference of -0.34 % in Body Corp- Liability Partnership’s financial performance between quarters.Paresh Mohanlal Parekh had 1.12% of shares in the previous quarter but exited in the current quarter.Vijay Mohanlal Parekh had 1.13% of shares in the previous quarter but exited in the current quarter.Jhunjhunwala Rekha Rakesh had 1.94% of shares in the previous quarter but exited in the current quarter.Enam Securities had 1.04% of shares in the previous quarter but exited in the current quarter.Lakshdeep Investments & Finance . had 1.86% of shares in the previous quarter but exited in the current quarter.
Below is a detailed table presenting the shareholding percentage of DIIs.
Shareholder Name |
Previous Quarter Quantity |
Current Quarter Quantity |
Previous Quarter Shares (in %) |
Current Quarter Shares (in %) |
Quarter-to-Quarter Difference (%) |
Mutual Funds/ |
3.36 Lakh |
16.39 Lakh |
0.1 |
0.51 |
+ 0.41 % |
Insurance Companies |
15.76 K |
18.87 K |
0 |
0.01 |
+ 0.01 % |
The latest quarter saw a considerable enhancement in stakeholding for Mutual Funds/, reflecting an uptick of 0.41 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Insurance Companies, reflecting an uptick of 0.01 % in their shares.
The table below displays the shareholding percentage of FIIs.
Shareholder Name |
Previous Quarter Quantity |
Current Quarter Quantity |
Previous Quarter Shares (in %) |
Current Quarter Shares (in %) |
Quarter-to-Quarter Difference (%) |
Foreign Portfolio Investors Category I |
66.21 Lakh |
68.36 Lakh |
2.04 |
2.11 |
+ 0.07 % |
Foreign Portfolio Investors Category II |
3.49 Lakh |
3.96 Lakh |
0.11 |
0.12 |
+ 0.01 % |
During this past quarter, there was a noteworthy upswing in stakeholding for Foreign Portfolio Investors Category I, which experienced a significant increase of 0.07 % .During this past quarter, there was a noteworthy upswing in stakeholding for Foreign Portfolio Investors Category II, which experienced a significant increase of 0.01 % .
Jhunjhunwala Rekha Rakesh, these shareholders are the Anchor investors of current and previous quarter. [my_shortcode1 values=”Sun Pharma Advanced Research C”]